The leadership team at Versant Ventures has a wide range of experience in the pharmaceutical and biotech industries. The CEO, Highline Therapeutics, has experience as the Global Program Team Director at Novartis and as an Assistant to the CEO at Novartis International AG. The Board Observer at LENZ Therapeutics and Board Observer at RayzeBio also has experience in strategy and operations from their time as an Associate at Northern Biologics. The team is rounded out with a Director at PwC, Board Member at Matterhorn Biosciences, and Board Member at Vector BioPharma, all with experience in different aspects of the pharma industry.
Alex Mayweg
Managing Director
Angela McDonald
Entrepreneur-in-Residence
Brad Bolzon
Chairman & Managing Director
Brian Busser
Entrepreneur-in-Residence
Carlo Rizzuto
Partner
Cathy Dring
Legal Counsel
Clare Ozawa
Managing Director
Elizabeth Alcamo
Entrepreneur-in-Residence
Guido Magni
Partner
Jerel Davis
Managing Director
Joel Drewry
Principal
Kim Macniak
Controller
Lara Hoth
VP, Management Company Finance...
Marcelo Bigal
Venture Partner
Markus Enzelberger
Partner
Markus Warmuth
Venture Partner
Max Eisenberg
General Counsel
Peppi Prasit
CEO Emeritus, Inception Scienc...
Peter Emtage
Entrepreneur-in-Residence
Rachel Lane
Principal
Robin Praeger
Managing Director & Advisor
Steve Edelson
VP, IR & Communications
Tom Frohlich
Entrepreneur-in-Residence
Tom Woiwode
Managing Director
View all